Literature DB >> 19155397

Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging.

Rachel F Brem1, Marina Ioffe, Jocelyn A Rapelyea, Kristen G Yost, Jean M Weigert, Margaret L Bertrand, Lillian H Stern.   

Abstract

OBJECTIVE: The objective of our study was to compare the sensitivity of mammography, sonography, MRI, and breast-specific gamma imaging (BSGI) in the detection of invasive lobular carcinoma.
MATERIALS AND METHODS: This is a retrospective multicenter study of women with biopsy-proven invasive lobular carcinoma. All patients had undergone mammography and BSGI, and the imaging findings were classified as positive or negative for invasive lobular carcinoma by experienced breast imagers. The results of MRI and sonography, if either was performed, were included. Final surgical pathology results were used as the reference standard and the lesion sensitivities of BSGI, mammography, sonography, and MRI were then statistically compared using CIs.
RESULTS: Twenty-six women ranging in age from 46 to 82 years (mean age, 62.8 years) with a total of 28 biopsy-proven invasive lobular carcinomas were included in the study group. Mammograms were negative in six of 28 (21%), yielding a sensitivity of 79%. In the 25 patients who underwent sonography, 17 had focal hypoechoic areas, yielding a sensitivity of 68%. In the 12 patients who underwent MRI, the sensitivity was 83%. BSGI had a sensitivity of 93%. There was no statistically significant difference in the sensitivity of BSGI, MRI, sonography, or mammography, although there was a nonsignificant trend toward improved detection with BSGI.
CONCLUSION: BSGI has the highest sensitivity for the detection of invasive lobular carcinoma with a sensitivity of 93%, whereas mammography, sonography, and MRI showed sensitivities of 79%, 68%, and 83%, respectively. BSGI is an effective technique that should be used to evaluate patients with suspected cancer and has a promising role in the diagnosis of invasive lobular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155397     DOI: 10.2214/AJR.07.3827

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Investigating the limit of detectability of a positron emission mammography device: a phantom study.

Authors:  Nicholas A Shkumat; Adam Springer; Christopher M Walker; Eric M Rohren; Wei T Yang; Beatriz E Adrada; Elsa Arribas; Selin Carkaci; Hubert H Chuang; Lumarie Santiago; Osama R Mawlawi
Journal:  Med Phys       Date:  2011-09       Impact factor: 4.071

2.  Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment.

Authors:  Ndeke Nyirenda; Daniel L Farkas; V Krishnan Ramanujan
Journal:  Breast Cancer Res Treat       Date:  2010-05-06       Impact factor: 4.872

3.  Dual-modality breast tomosynthesis.

Authors:  Mark B Williams; Patricia G Judy; Spencer Gunn; Stanislaw Majewski
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

4.  Development of array piezoelectric fingers towards in vivo breast tumor detection.

Authors:  Xin Xu; Youngsoo Chung; Ari D Brooks; Wei-Heng Shih; Wan Y Shih
Journal:  Rev Sci Instrum       Date:  2016-12       Impact factor: 1.523

5.  Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinoma.

Authors:  Sung Hun Kim; Eun Suk Cha; Chang Suk Park; Bong Joo Kang; In Yong Whang; A Won Lee; Byung Joo Song; Jeongmi Park
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

Review 6.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

Review 7.  CDH1 germline mutations and hereditary lobular breast cancer.

Authors:  Giovanni Corso; Mattia Intra; Chiara Trentin; Paolo Veronesi; Viviana Galimberti
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

8.  Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).

Authors:  Francesco Amato; Giulia Bicchierai; Donatello Cirone; Catherine Depretto; Federica Di Naro; Ermanno Vanzi; Gianfranco Scaperrotta; Tommaso Vincenzo Bartolotta; Vittorio Miele; Jacopo Nori
Journal:  Radiol Med       Date:  2019-11-26       Impact factor: 3.469

9.  Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade.

Authors:  R V Tadwalkar; J A Rapelyea; J Torrente; L R Rechtman; C B Teal; A P McSwain; C Donnelly; A B Kidwell; C M Coffey; R F Brem
Journal:  Br J Radiol       Date:  2011-06-28       Impact factor: 3.039

Review 10.  Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis.

Authors:  Yu Sun; Wei Wei; Hua-Wei Yang; Jian-Lun Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.